IDEAYA Biosciences, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · South San Francisco, CA
IDYA chart
What traders are saying about $IDYA
Latest postsIDEAYA Biosciences, Inc. news
- IDEAYA Biosciences, Inc. (IDYA) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- IDEAYA Biosciences, Inc. (IDYA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Yahoo Finance ·
- Citizens reiterates Ideaya Biosciences stock rating on darovasertib data By Investing.com
Investing.com Nigeria ·
- Is IDEAYA Biosciences (IDYA) A Bargain After New ESMO Trial Data?
Simply Wall Street ·
- IDEAYA Biosciences, Inc. Estimates – NASDAQ:IDYA
TradingView ·
- Ideaya Biosciences announces updated clinical results from IDE849 trial
TipRanks ·
- IDE849 (SHR-4849) DLL3 TOP1 ADC Updated Phase 1 Results at ESMO 2026 Demonstrates Promising Anti-Tumor Activity and Preliminary Overall Survival Results in Relapsed Small Cell Lung Cancer and Neuroendocrine Carcinomas
Yahoo Finance ·
- 17.4 months was median survival after one prior treatment in an early small-cell lung cancer study.
Stock Titan ·
- William Blair Expands Biotech Research as Veteran Analyst Alethia Young Initiates Coverage
Yahoo Finance ·
- IDEAYA Biosciences and Servier Announce Data From Three Clinical Trials at ESMO 2026 Supporting the Potential of Darovasertib to Become a Foundational New Therapy for Patients Across the Treatment Journey of Uveal Melanoma
Yahoo Finance ·
- IDEAYA Biosciences (IDYA) Rethinks Its R And D Leadership As Undervaluation Questions Grow
Yahoo Finance ·
- IDEAYA Biosciences Announces the Promotion of Dr. Michael White to President, Research and Development
Yahoo Finance ·
IDEAYA Biosciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $218.7M | $7.0M | $23.4M | $50.9M |
| Net income | -$113.7M | -$274.5M | -$113.0M | -$58.7M |
| Diluted EPS | $-1.28 | $-3.36 | $-1.96 | $-1.42 |
| Total assets (year end) | $1.11B | $1.12B | $649.3M | $388.0M |
| Cash and equivalents (year end) | $112.8M | $84.4M | $157.0M | $68.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About IDEAYA Biosciences, Inc.
- Ticker
- IDYA (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- South San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1676725
Frequently asked questions
What exchange is IDEAYA Biosciences, Inc. listed on?
IDEAYA Biosciences, Inc. trades on the Nasdaq under the ticker symbol IDYA.
What industry is IDEAYA Biosciences, Inc. in?
IDEAYA Biosciences, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is IDEAYA Biosciences, Inc. headquartered?
IDEAYA Biosciences, Inc.'s business address on file with the SEC is in South San Francisco, CA.
When does IDEAYA Biosciences, Inc.'s fiscal year end?
IDEAYA Biosciences, Inc.'s fiscal year ends on December 31.
How much revenue did IDEAYA Biosciences, Inc. report?
IDEAYA Biosciences, Inc. reported $218.7M in revenue for calendar year 2025, according to its SEC filings.